Profund Advisors’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12M Buy
124,082
+8,567
+7% +$135K 0.04% 321
2025
Q4
$2.11M Buy
115,515
+31,047
+37% +$523K 0.06% 206
2025
Q3
$1.24M Buy
84,468
+19,697
+30% +$338K 0.04% 283
2025
Q2
$1.18M Buy
64,771
+9,576
+17% +$195K 0.04% 264
2025
Q1
$1.1M Sell
55,195
-51,232
-48% -$886K 0.05% 276
2024
Q4
$1.83M Buy
106,427
+20,215
+23% +$380K 0.07% 193
2024
Q3
$1.72M Buy
86,212
+32,029
+59% +$498K 0.07% 216
2024
Q2
$606K Sell
54,183
-53,803
-50% -$451K 0.02% 442
2024
Q1
$713K Buy
107,986
+16,913
+19% +$92.4K 0.03% 456
2023
Q4
$412K Sell
91,073
-16,080
-15% -$59.5K 0.02% 619
2023
Q3
$384K Sell
107,153
-24,556
-19% -$94.5K 0.02% 549
2023
Q2
$486K Sell
131,709
-50,704
-28% -$188K 0.03% 522
2023
Q1
$604K Buy
+182,413
New +$631K 0.04% 450

Other funds holding ADMA